Clare Cutland to Neisseria meningitidis
This is a "connection" page, showing publications Clare Cutland has written about Neisseria meningitidis.
Connection Strength
0,812
-
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5?years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children. Vaccine. 2023 01 27; 41(5):1153-1160.
Score: 0,812